MedTrace Logo

Outcome Following Antidepressant Treatment on Possible Endo-Phenotypes for Major Depression

NCT00386841 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2009-06-30

No results posted yet for this study

Summary

The purpose of this study is to determine whether outcome following antidepressant treatment can be used as a tool to evaluate endo-phenotypes for depression.

Conditions

  • Healthy

Interventions

DRUG

Escitalopram

Escitalopram 10 mg p.o. per day

DRUG

Placebo

Placebo

Sponsors & Collaborators

  • University of Copenhagen

    lead OTHER

Principal Investigators

  • Lars V Kessing, DMSc · Psychiatric Department of Rigshospitalet, Blegdamsvej 9, DK-2100 Copenhagen OE

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-04-30
Primary Completion
2009-06-30
Completion
2009-06-30

Countries

  • Denmark

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00386841 on ClinicalTrials.gov